Rio de Janeiro HIV Clinical Forum – presentations

 

WEDNESDAY 22 AUGUST

 Session 1  -  Antiretroviral Drug Resistance
 Resistance to Integrase Inhibitors
Charles Boucher, MD, PhD
Erasmus Medical Center, Rotterdam, The Netherlands
 Transmitted resistance to ARVs and its impact on initial therapy
Ricardo Díaz, MD
Universidade Federal de São Paulo, São Paulo, Brazil
  
 Session 2  -  Integrase Inhibitors in Special Populations
 DDIs, INSTIs, TB and hepatitis
David Back, PhD
University of Liverpool, Liverpool, United Kingdom
 INSTIs in women and pregnancy
Sharon Walmsley, FRCPC, MD, MSc
University Health Network, Toronto, Canada
 HIV prevention and the role of integrase inhibitors
Pep Coll, MD
Hospital Universitari Germans Trias i Pujol, Badalona, Spain
 Clinical case presentation
Marcio de Figueiredo Fernandes, MD
Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil
  
 Session 3  -  Clinical Utility of Integrase Inhibitors
 SIERJ SESSION: Is early ART for everyone?
Mauro Schechter, MD, PhD
Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil
 Optimal use of INSTI’s in routine practice 
Carlos Brites, MD, PhD
Universidade Federal da Bahia, Salvador, Brazil
 Clinical case presentation 
Tânia Vergara, MD, PhD
Sociedade de Infectologia do Rio de Janeiro, Rio de Janeiro, Brazil
  
 Session 4  -  Future Treatment Options
 Simplified regimens: pros and cons
Pedro Cahn, MD, PhD
Fundación Huésped, Buenos Aires, Argentina
 Future perspective for delivery of antiretroviral drugs
David Back, PhD
University of Liverpool, Liverpool, United Kingdom